Monsanto Reaffirms 2012 Financial Guidance
Monsanto Company (NYSE: MON) Chief Executive Officer Hugh Grant today will detail the company’s strategic path to deliver mid-teens earnings for 2012 and set up continued growth going forward, explaining to investors how the company’s next growth phase in agriculture reflects Monsanto’s preeminence as a yield company.
Yield Opportunity Reflected in Fiscal Year 2012 Mid-Teens Outlook
Looking at growth opportunities by region, the company expects international markets to represent a significant percentage of its growth, driven by the ascension of Latin America. Growth in the U.S. market is expected to come from upgrades in germplasm and traits and increased volume as Monsanto expands its Genuity® Roundup Ready 2 Yield® platform in soybeans and Genuity® reduced refuge family in corn.
The company reaffirmed its earnings per share guidance of $3.34 to $3.44 for fiscal year 2012, when top-line growth is expected to come from seeds and traits as the business continues to benefit from mix upgrades and diversification geographically and across crops. The company also guided to the high end of its first quarter earnings forecast of $0.10 to $0.15 per share, reflecting the performance of the early Latin American planting season, where increased acres and broad business growth underscore the opportunity in this region. (For a reconciliation of earnings per share, see note 1.)
The company continues to project free cash flow in the range of $1.3 billion to $1.5 billion for fiscal year 2012. The company expects net cash provided by operating activities to be $2.2 billion to $2.5 billion, and net cash required by investing activities to be approximately $900 million to $1 billion for fiscal year 2012.
Source:
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.
| Online: | |
| Visits: | 1,609,638,692 |
| Stories: | 8,168,274 |
Whistler Blowers, Insiders
